Nature Portfolio aims to enhance the reproducibility of published research through structured and transparent reporting. The document outlines specific requirements for statistical analyses, data availability, and research involving human participants or biological materials. Key points include: - **Statistics**: Ensure that all statistical analyses are clearly described, including sample size, type of measurements, statistical tests used, covariates, assumptions, and parameters. - **Data**: All manuscripts must include a data availability statement, providing access codes, unique identifiers, or web links for publicly available datasets, along with any restrictions on data access. - **Human Participants and Biological Materials**: Full information on study protocol approval must be provided. Authors should select the most relevant field-specific reporting guidelines (life sciences, behavioral & social sciences, ecological, evolutionary & environmental sciences). - **Materials & Experimental Systems**: Indicate whether specific materials, systems, or methods are involved in the study, such as antibodies, eukaryotic cell lines, animals, clinical data, and plants. - **Methods**: Provide details on methods used, such as ChIP-seq, flow cytometry, and MRI-based neuroimaging. For more detailed information, refer to the [Editorial Policies](#) and the [Editorial Policy Checklist](#).Nature Portfolio aims to enhance the reproducibility of published research through structured and transparent reporting. The document outlines specific requirements for statistical analyses, data availability, and research involving human participants or biological materials. Key points include: - **Statistics**: Ensure that all statistical analyses are clearly described, including sample size, type of measurements, statistical tests used, covariates, assumptions, and parameters. - **Data**: All manuscripts must include a data availability statement, providing access codes, unique identifiers, or web links for publicly available datasets, along with any restrictions on data access. - **Human Participants and Biological Materials**: Full information on study protocol approval must be provided. Authors should select the most relevant field-specific reporting guidelines (life sciences, behavioral & social sciences, ecological, evolutionary & environmental sciences). - **Materials & Experimental Systems**: Indicate whether specific materials, systems, or methods are involved in the study, such as antibodies, eukaryotic cell lines, animals, clinical data, and plants. - **Methods**: Provide details on methods used, such as ChIP-seq, flow cytometry, and MRI-based neuroimaging. For more detailed information, refer to the [Editorial Policies](#) and the [Editorial Policy Checklist](#).